THE PUBLICATION OF SPONSORED SYMPOSIUMS IN MEDICAL JOURNALS
THE PUBLICATION OF SPONSORED SYMPOSIUMS IN MEDICAL JOURNALS
复制标题
DOI：
10.1056/nejm199210153271606
复制
发表时间：
1992-10-15
影响因子：
158.5
通讯作者：
RENNIE, D
中科院分区：
文献类型：
--
作者：
BERO, LA;GALBRAITH, A;RENNIE, D
背景制药业越来越多的支出用于资助由同行评审的医学期刊发表的研讨会。本研究测试的假设，这种赞助，特别是由一个单一的制药公司，是与宣传导向的专题讨论会和扭曲的同行评审过程。我们统计了58种临床医学期刊上发表的专题讨论会，并调查了期刊编辑对专题讨论会问题的政策。我们分析了发表研讨会最多的11种期刊中出现的研讨会问题，以确定赞助商或赞助商，主题，标题是否具有误导性，是否使用品牌名称，以及特色药物是否被食品和药物管理局归类为创新或批准。从1966年到1989年，每年出版的专题讨论会数量稳步增加。42%的被分析者（625人中的262人）有一家制药公司作为赞助商。这些研讨会比有其他赞助商的研讨会更有可能具有误导性的标题（P
Background. An increasing proportion of spending by the pharmaceutical industry has gone to funding symposiums that are published by peer-reviewed medical journals. This study tests the hypothesis that such sponsorship, particularly by a single pharmaceutical company, is associated with a promotional orientation of the symposium and a distortion of the peer-review process.Methods. We counted the symposiums published in 58 journals of clinical medicine and surveyed the journal editors regarding their policies for symposium issues. We analyzed the symposium issues that appeared in the 11 journals that published the most symposiums in order to determine the sponsor or sponsors, the topics, whether the titles were misleading, whether brand names were used, and whether the featured drugs were classified by the Food and Drug Administration as innovative or approved.Results. The number of symposiums published per year increased steadily from 1966 through 1989. Forty-two percent of those analyzed (262 of 625) had a single pharmaceutical company as the sponsor. These symposiums were more likely than those with other sponsors to have misleading titles (P